NIKKEI|TOPIXThe Nikkei 225 closed at 67,744.29, essentially flat (-0.05%), but the prior session's broader context of a multi-day losing streak (down approximately 4.9–5% to around 64,426 in the session before) underlines elevated volatility — Nikkei VIX stands at 28.09, though it fell 7.63% on the session. TOPIX sector performance was led by Energy Resources (+1.37%), Autos & Transport (+0.90%), and Pharma (+0.85%), while Banks were the clear laggard at -2.34%, an apparent divergence from the higher-rate environment that would typically support net interest margins.
NIKKEI|TOPIXNikkei 225 top gainers were concentrated in pharmaceuticals: Sumitomo Pharma (4506.T) surged 15.81%, Ryohin Keikaku (7453.T) jumped 9.51%, Takeda Pharmaceutical (4502.T) rose 4.99%, Otsuka Holdings (4578.T) gained 4.66%, and Astellas Pharma (4503.T) added 4.15%. The pharma rotation appears to reflect a defensive realignment away from technology names amid elevated rate and global growth uncertainty.
NIKKEI|TOPIXNikkei 225 top losers were dominated by semiconductor and technology-linked names: Advantest (6857.T) fell 14.96%, Sumco (3436.T) dropped 13.85%, Lasertec (6920.T) declined 13.56%, Mitsui Kinzoku (5706.T) lost 13.14%, and Furukawa Electric (5801.T) fell 13.10%. The sell-off in chip-related names mirrors the US pattern of AI and semiconductor de-rating driven by financing cost concerns and the broader Nvidia/AMD/Micron declines overnight.
KOREA|KOSPIThe KOSPI closed at 6,008.81 (-0.44%) on Thursday 15 October, but context from the prior session is critical: the index plunged 7.57% with a circuit breaker triggered, with Samsung Electronics (005930.KS) falling approximately 9.9% and SK Hynix (000660.KS) dropping more than 11%. This represents the seventh consecutive session of declines for the index and places Korean semiconductor equities at the epicentre of the global AI capex and rate-sensitivity sell-off.
JPY|BOJUSD/JPY sits at 158.09, up just 0.08% on the session, a relatively muted move given BoJ board member Koeda's hawkish October 15 remarks citing upside inflation risks and a neutral rate 'considerably above 1%.' Markets appear to be weighing Koeda's comments against the backdrop of a December — rather than October — rate hike as the base case, limiting yen appreciation despite the hawkish signal. Japanese exporters including Toyota (7203.T) and the broader auto sector remain sensitive to any further yen strengthening.
CNY|PBOC|SSEThe Shanghai Composite fell 0.89% to 3,767.23 as the PBOC set a firmer USD/CNY fixing at approximately 6.7253 versus a spot rate of 6.6904, with Governor Pan Gongsheng's comments on global imbalances interpreted as signalling continued moderate policy support rather than aggressive easing. With China's Q3 GDP print due around October 19 and the IMF calling for larger fiscal stimulus, the policy trajectory and domestic demand outlook remain key variables for SSE and HKEX-listed names with China revenue exposure.